TISLELIZUMAB-JSGR | B761232 | BEIGENE
Regulatory Exclusivities
| Type | Expiry | Status | Source |
|---|---|---|---|
| 12-Year BPCIA | Mar. 13, 2036 | Active | Computed |
| 7-Year Orphan | Mar. 13, 1931 | Expired | Purple Book |
Purple Book Patents
No listed patents in Purple Book.
Estimated Patent LOE
Based on latest discovered patent 12429485(diagnostic) · relevance 80/100
Estimate based on AI-discovered patents. No patents are officially listed in the Purple Book for this product.
9 AI-discovered patents, sorted by relevance.
No patent or exclusivity listings for this strength.